Abundant scores key e-commerce partnership to drive China sales

Published 02-JUL-2018 12:06 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Abundant Natural Health (ANH) — a wholly owned subsidiary of Abundant Produce Limited (ASX:ABT) — has penned a pivotal e-commerce agreement with Hui Yi (Beijing) International Trade Co. Ltd to drive sales in China.

The agreement will expedite and encourage sales of ANH’s nutraceutical and cosmetic product ranges on Chinese e‐commerce giant, JD Global’s online platform, JD.hk.

Hui Yi will support ANH’s push into China by taking responsibility for the daily operations and maintenance of ANH’s online store on JD.hk.

Hui Yi has extensive experience within China in brand marketing and strategic activation, including sales channel management.

Hui Yi will work closely with ANH management to devise sales and marketing campaigns that clearly articulate the brand message and benefits across the entire ANH skincare and nutraceuticals range.

Running for an initial period of 12 months, the agreement will also see Hui Yi plan and execute promotional activities to drive traffic and conduct competitor brand and market analysis.

This will include promotion of ANH’s full range of ActiveLycoTM infused face products, magnesium-enriched nutraceuticals and salt skin cleansing gels to Chinese consumers on JD.hk.

The key extract which forms the basis of ANH’s ActiveLycoTM range is lycopene — a potent antioxidant which fights signs of aging, combats skin damage from sun exposure and provides relief from irritable skin conditions.

Launch of Abundant’s entire ANH-branded cosmetic and nutraceutical range on JD.hk is expected in the third quarter of 2018.

As China’s largest overall retailer in terms of revenue, JD Global offers ANH an unparalleled nationwide fulfilment network, with 486 warehouses servicing some 302 million active users.

However, growth is speculative and if considering this stock for your portfolio, you should take all public information into account and seek professional financial advice.

ANH CEO, Shanan Birkin, said: “Securing Hui Yi as our e-commerce partner represents a significant development for ANH, and for Abundant Produce more broadly. The agreement will accelerate our traction with customers through the largest online retail channel in the most exciting global market for organic cosmetics and nutraceuticals.”

“We are delighted that our innovative skincare offering is being recognised on an international level and look forward to growing sales rapidly in China with Hui Yi’s support,” said Birkin.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X